Valerie Daggett

Company: AltPep Corporation

Job title: Founder & Chief Executive Officer

Seminars:

Diagnostics and Therapeutics for Selective Targeting of Early Toxic Oligomers 10:00 am

Highly specific and sensitive plasma Soluble Oligomer Binding Assay (SOBA) with FDA breakthrough designation for AD Soluble Oligomer Binding Inhibitor (SOBIN) for neutralization of toxic oligomers and their effects in vivo SOBA test applicable to other amyloid diseases, including PDRead more

day: Blood-Based Biomarker Focus Day